CANTON, Mass., Jan. 20 /PRNewswire-FirstCall/ -- Avitar, Inc. (Amex: - ) today announced that William Schoff has been named National Sales Manager.
Prior to joining Avitar, Mr. Schoff has had over 25 years of distinguished experience in the healthcare industry. He has held numerous sales and sales management positions at major companies, including National Medical Care and Spectra Renal Management, and was President of Lifetech, a national independent sales representative organization.
"We are very pleased to promote Bill to this very important sales management position," said Peter Phildius. "He has demonstrated success in advancing rapid growth and generating substantial profits in both turnaround and start-up environments."
Avitar, Inc. develops, manufactures and markets innovative and proprietary products in the oral fluid diagnostic market, disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of- abuse testing market, which encompasses the corporate workplace and criminal justice markets. Avitar's products include ORALscreen(TM), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, and HAIRscreen(TM), a laboratory-based hair test for detecting long-term drug abuse. Additionally, Avitar manufactures and markets HYDRASORB(TM), an absorbent topical dressing for moderate to heavy exudating wounds. In the estimated $25 billion in vitro diagnostics market, Avitar is developing diagnostic strategies for disease and clinical testing. Some examples include influenza, diabetes and pregnancy. For more information, see Avitar's website at avitarinc.com.
Safe Harbor Statement
This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements.
Chief Financial Officer